0001140361-24-025182.txt : 20240509 0001140361-24-025182.hdr.sgml : 20240509 20240509161248 ACCESSION NUMBER: 0001140361-24-025182 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240509 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quantum-Si Inc CENTRAL INDEX KEY: 0001816431 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 851388175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39486 FILM NUMBER: 24930751 BUSINESS ADDRESS: STREET 1: 29 BUSINESS PARK DRIVE CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: (203) 458-7100 MAIL ADDRESS: STREET 1: 29 BUSINESS PARK DRIVE CITY: BRANFORD STATE: CT ZIP: 06405 FORMER COMPANY: FORMER CONFORMED NAME: HighCape Capital Acquisition Corp. DATE OF NAME CHANGE: 20200629 8-K 1 ef20028707_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 9, 2024


QUANTUM-SI INCORPORATED
(Exact name of registrant as specified in its charter)


Delaware
001-39486
85-1388175
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

29 Business Park Drive
Branford, Connecticut
06405
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: (866) 688-7374

N/A
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading
Symbol(s)
Name of each
exchange on
which registered
Class A common stock, par value $0.0001 per share
QSI
The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
QSIAW
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.
Results of Operations and Financial Condition.
 
On May 9, 2024, Quantum-Si Incorporated (the “Company”) issued a press release announcing its results for the first quarter ended March 31, 2024 and providing a business update. A copy of the press release is furnished as Exhibit 99.1 hereto.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits.

Exhibit
No.
Description




Press Release dated May 9, 2024

Use of Non-GAAP Financial Measures
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
QUANTUM-SI INCORPORATED



By:
/s/ Jeffry Keyes

Name:
Jeffry Keyes

Title:
Chief Financial Officer



Date:          May 9, 2024



EX-99.1 2 ef20028707_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1


Quantum-Si Reports First Quarter 2024 Financial Results
Executed Full Commercial Launch of Platinum® Instrument
Reaffirms Full Year 2024 Financial Guidance

BRANFORD, Conn. -- (BUSINESS WIRE) – May 9, 2024 -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced financial results for the first quarter ended March 31, 2024.

Press Release Highlights
●
Reported revenue of $457,000 in the first quarter of 2024
●
Commenced its full commercial launch of its Platinum® instrument at the end of March 2024
●
On track to launch version 3 of its sequencing kit, which is expected by the end of Q3 2024
●
Announced addition of Paula Dowdy to the Board of Directors
●
Announced the release of a new version of Platinum® Analysis Software
●
Reaffirmed full year 2024 financial guidance

“We concluded our first quarter of 2024 with great momentum on all fronts, including initiation of the full commercial launch of Platinum.  Now that we have emerged from a controlled launch, we expect to generate steady quarter-over-quarter revenue growth as we move forward for the rest of the year.   In addition to initiating our full commercial launch of Platinum in the first quarter, we also secured our first government and pharma customers.  While academic research will remain an attractive market segment for the company, we are excited about the momentum we are seeing in these new market segments and the potential they represent for expanding our instrument adoption and utilization in the future,” said Jeff Hawkins, President and Chief Executive Officer of Quantum-Si.

Hawkins continued, “On the R&D front, we have made great progress on version 3 of our sequencing kit and we continue to expect to deliver it to the market by the end of Q3 2024.  In addition to our version 3 sequencing kit, we have made steady progress on other development programs, including our library preparation kit, instrumentation roadmap and analysis software tools.  Finally, we continue to enhance our Board of Directors, with the recent addition of Paula Dowdy to our Board.  Her extensive global commercial experience, and specifically, her depth of knowledge in the life sciences markets in EMEA, will be very valuable as we progress with our full commercial launch of Platinum.”

First Quarter 2024 Financial Results
At the end of the first quarter of 2024, the Company concluded its controlled commercial launch of its Platinum® instrument, recording revenue of $457,000 for the quarter.  Gross profit was $269,000 and gross margin was 59%. The periodic gross margin rate is expected to be variable in the near term as the Company works through the initial stages of commercialization as well as the timing and mix of product sales between instruments and consumable kits.

Total operating expenses were $23.6 million in the first quarter of 2024, compared to $29.3 million for the same period in the prior year. Adjusted total operating expenses were $21.9 million in the first quarter of 2024, compared to $24.6 million for the same period in the prior year.  Driven by the Company’s 2023 initiative to enact operating changes to utilize capital in the most efficient manner while accelerating R&D innovation and delivering product enhancements to customers, the overall adjusted operating expenses included reductions in R&D and G&A spend, partially offset with increased spending for commercial operations.  Overall, the Company has been able to reduce core areas of spend while accelerating R&D focus, efficiency, and delivery while still funding the Company’s full commercial launch of its Platinum® instrument.

Net loss was $19.5 million in the first quarter of 2024, compared to a net loss of $23.6 million in the same period of the prior year. Adjusted EBITDA was negative $20.5 million in the first quarter of 2024, compared to negative $23.7 million in the same period of the prior year.  A reconciliation of the non-GAAP financial measures, adjusted total operating expenses and adjusted EBITDA, is provided in a table included in this press release.

As of March 31, 2024, the Company’s cash and cash equivalents and investments in marketable securities were $235.4 million.

2024 Financial Guidance
The Company reaffirms its full year 2024 financial guidance as follows:

Revenue
 $3.7 - $4.2 million
Adjusted total operating expenses
Less than $103 million
Total cash usage
 Less than $100 million

The Company also maintains the expectation that the balance in cash and cash equivalents and investments in marketable securities of $235.4 million as of March 31, 2024 will provide a runway into 2026.

Webcast and Conference Call Information
Quantum-Si will host a conference call to discuss its first quarter 2024 financial results on Thursday, May 9, 2024, at 4:30 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by joining the live webcast in the Investors section of the Quantum-Si website under Events & Presentations. Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.

About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.

Use of Non-GAAP Financial Measures
This press release presents the non-GAAP financial measures “adjusted total operating expenses” and “adjusted EBITDA.” The most directly comparable measures for these non-GAAP financial measures are total operating expenses and net loss. The Company has included below adjusted total operating expenses, which presents the Company’s total operating expenses after excluding goodwill impairment, stock-based compensation and restructuring costs.  In addition, adjusted EBITDA further excludes interest, taxes, depreciation, amortization, dividend income, unrealized and realized gains and losses on marketable securities, changes in fair value of warrant liabilities and other income or expense.

A discussion of the reasons why management believes that the presentation of non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations is included as Exhibit 99.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on May 9, 2024.

Forward Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. The actual results of the Company may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations with respect to future performance and development and commercialization of products and services, its anticipated cash runway and its financial guidance for the full year 2024. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the Company's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the inability to maintain the listing of the Company's Class A common stock on The Nasdaq Stock Market; the ability of the Company to grow and manage growth profitably and retain its key employees; the Company’s ongoing leadership transitions; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success, cost and timing of the Company's product development and commercialization activities; the commercialization and adoption of the Company’s existing products and the success of any product the Company may offer in the future; the potential attributes and benefits of the Company’s commercialized Platinum® protein sequencing instrument and kits and the Company’s other products once commercialized; the Company's ability to obtain and maintain regulatory approval for its products, and any related restrictions and limitations of any approved product; the Company's ability to identify, in-license or acquire additional technology; the Company's ability to maintain its existing lease, license, manufacture and supply agreements; the Company's ability to compete with other companies currently marketing or engaged in the development or commercialization of products and services that serve customers engaged in proteomic analysis, many of which have greater financial and marketing resources than the Company; the size and growth potential of the markets for the Company's products and services, and its ability to serve those markets once commercialized, either alone or in partnership with others; the Company's estimates regarding future expenses, future revenue, capital requirements and needs for additional financing; the Company's financial performance; and other risks and uncertainties described under "Risk Factors" in the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in the Company's other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.

QUANTUM-SI INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and par value amounts)
(Unaudited)



   
March 31,
2024
      
December 31,
2023
   
Assets
            
Current assets:
            
Cash and cash equivalents
  
$
53,163
    
$
133,860
  
Marketable securities
    
182,268
      
123,876
  
Accounts receivable, net of allowance of $0 and $0, respectively
    
242
      
368
  
Inventory, net
    
4,946
      
3,945
  
Prepaid expenses and other current assets
    
3,756
      
4,261
  
Total current assets
    
244,375
      
266,310
  
Property and equipment, net
    
16,169
      
16,275
  
Internally developed software
    
496
      
532
  
Operating lease right-of-use assets
    
13,850
      
14,438
  
Other assets
    
695
      
695
  
Total assets
  
$
275,585
    
$
298,250
  
Liabilities and stockholders' equity
                
Current liabilities:
                
Accounts payable
  
$
1,164
    
$
1,766
  
Accrued expenses and other current liabilities
    
5,198
      
8,277
  
Current portion of operating lease liabilities
    
1,610
      
1,566
  
Total current liabilities
    
7,972
      
11,609
  
Warrant liabilities
    
955
      
1,274
  
Operating lease liabilities
    
12,873
      
13,737
  
Other long-term liabilities
    
14
      
11
  
Total liabilities
    
21,814
      
26,631
  
                 
Stockholders' equity
                
Class A Common stock, $0.0001 par value; 600,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 121,878,989 and 121,832,417 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively.
    
12
      
12
  
Class B Common stock, $0.0001 par value; 27,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 19,937,500 shares issued and outstanding as of March 31, 2024 and December 31, 2023.
    
2
      
2
  
Additional paid-in capital
    
768,898
      
767,239
  
Accumulated other comprehensive loss
    
(33
)
    
-
  
Accumulated deficit
    
(515,108
)
    
(495,634
)
Total stockholders' equity
    
253,771
      
271,619
  
Total liabilities and stockholders' equity
  
$
275,585
    
$
298,250
  

QUANTUM-SI INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except per share amounts)
(Unaudited)


  
Three months ended March 31,
  

 
2024
    
2023
  
Revenue
            
Product
  
$
428
    
$
251
  
Service
    
29
      
3
  
Total revenue
    
457
      
254
  
                 
Cost of revenue
    
188
      
130
  
                 
Gross profit
    
269
      
124
  
Operating expenses:
                
Research and development
    
12,101
      
18,167
  
Selling, general and administrative
    
11,528
      
11,178
  
Total operating expenses
    
23,629
      
29,345
  
Loss from operations
    
(23,360
)
    
(29,221
)
Dividend and interest income
    
3,574
      
2,219
  
Gain on marketable securities, net
    
-
      
2,942
  
Change in fair value of warrant liabilities
    
319
      
391
  
Other (expense) income, net
    
(7
)
    
58
  
Loss before provision for income taxes
    
(19,474
)
    
(23,611
)
Provision for income taxes
    
-
      
-
  
Net loss
  
$
(19,474
)
  
$
(23,611
)
                 
Net loss per common share attributable to common stockholders, basic and diluted
  
$
(0.14
)
  
$
(0.17
)
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted
    
141,773
      
140,280
  
                 
Other comprehensive loss:
                
Net unrealized loss on marketable securities, net of tax
  
$
(28
)
  
$
-
  
Foreign currency translation adjustment
    
(5
)
    
-
  
Total other comprehensive loss, net of tax
    
(33
)
    
-
  
Comprehensive loss
  
$
(19,507
)
  
$
(23,611
)

QUANTUM-SI INCORPORATED
RECONCILIATION OF U.S. GAAP TO NON-GAAP FINANCIAL MEASURES
(in thousands)
(Unaudited)


  
Three months ended March 31,
  

 
2024
    
2023
  
Net loss
  
$
(19,474
)
  
$
(23,611
)
Adjustments to reconcile to EBITDA:
                
Dividend and interest income
    
(3,574
)
    
(2,219
)
Depreciation and amortization
    
1,061
      
803
  
EBITDA
    
(21,987
)
    
(25,027
)
Adjustments to reconcile to Adjusted EBITDA:
                
Gain on marketable securities, net
    
-
      
(2,942
)
Change in fair value of warrant liabilities
    
(319
)
    
(391
)
Other expense (income), net
    
7
      
(58
)
Stock-based compensation
    
1,609
      
3,908
  
Restructuring costs
    
143
      
813
  
Adjusted EBITDA
  
$
(20,547
)
  
$
(23,697
)


 
Three months ended March 31,
  

 
2024
    
2023
  
Total operating expenses
  
$
23,629
    
$
29,345
  
Adjustments to reconcile to Adjusted total operating expenses:
                
Stock-based compensation
    
(1,609
)
    
(3,908
)
Restructuring costs
    
(143
)
    
(813
)
Adjusted total operating expenses
  
$
21,877
    
$
24,624
  

Contacts
Investor Contact
Jeff Keyes, Chief Financial Officer
ir@quantum-si.com

Media Contact
Katherine Atkinson, SVP of Commercial Marketing
media@quantum-si.com
EX-99.2 3 ef20028707_ex99-2.htm EXHIBIT 99.2
Exhibit 99.2

Use of Non-GAAP Financial Measures

In addition to financial results calculated in accordance with U.S. generally accepted accounting principles (“GAAP”), information containing non-GAAP financial measures for Quantum-Si Incorporated (the “Company”) was disclosed in the Company's press release (the “Press Release”) dated May 9, 2024 announcing results for the three months ended March 31, 2024, that accompany a conference call to be held by the Company on May 9, 2024.  The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.  Management encourages readers to rely upon the reported GAAP results but includes the non-GAAP financial measures as supplemental metrics to assist readers. Definitions of the non-GAAP financial measures are included in the Press Release.

In the Press Release, the Company presented the non-GAAP financial measures “adjusted total operating expenses” and “adjusted EBITDA."  Company management uses these non-GAAP financial measures to evaluate the Company's performance.  As the Company's core business is developing and commercializing products associated with proteomics sequencing, Company management finds it useful to use adjusted total operating expenses, which excludes goodwill impairment, stock-based compensation and restructuring costs.  While the Company may have these types of items and charges in the future, Company management believes they are not reflective of the day-to-day core operations of the Company and relate more to strategic, multi-year corporate actions, without predictable trends, and that may obscure the trends and financial performance of the Company's core business. In the case of “adjusted EBITDA,” Company management believes the exclusion of interest, taxes, depreciation, amortization, goodwill impairment, dividend income, unrealized and realized gains and losses on marketable securities, changes in fair value of warrant liabilities, and other income or expense is a very common measure utilized in the investment community and it helps Company management benchmark its operations and results with the industry.

The limitation associated with using these non-GAAP financial measures is that these measures exclude items that impact the Company's current period operating results. This limitation is best addressed by using these non-GAAP financial measures in combination with “total operating expenses” and “net loss,” (the most comparable GAAP measures) because these non-GAAP financial measures do not reflect items that impact current period operating results and may be higher or lower than the most comparable GAAP measure.


 EX-101.SCH 4 qsi-20240509.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 5 qsi-20240509_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 qsi-20240509_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Common Stock [Member] Class of Stock [Domain] Class of Stock [Axis] Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member] EX-101.PRE 7 qsi-20240509_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 image00001.jpg begin 644 image00001.jpg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end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document and Entity Information
May 09, 2024
Entity Listings [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 09, 2024
Entity File Number 001-39486
Entity Registrant Name QUANTUM-SI INCORPORATED
Entity Central Index Key 0001816431
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-1388175
Entity Address, Address Line One 29 Business Park Drive
Entity Address, City or Town Branford
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06405
City Area Code 866
Local Phone Number 688-7374
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Common Stock [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Class A common stock, par value $0.0001 per share
Trading Symbol QSI
Security Exchange Name NASDAQ
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol QSIAW
Security Exchange Name NASDAQ
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 3 22 1 false 2 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://quantum-si.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ef20028707_8k.htm qsi-20240509.xsd qsi-20240509_def.xml qsi-20240509_lab.xml qsi-20240509_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ef20028707_8k.htm": { "nsprefix": "qsi", "nsuri": "http://quantum-si.com/20240509", "dts": { "inline": { "local": [ "ef20028707_8k.htm" ] }, "schema": { "local": [ "qsi-20240509.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "qsi-20240509_def.xml" ] }, "labelLink": { "local": [ "qsi-20240509_lab.xml" ] }, "presentationLink": { "local": [ "qsi-20240509_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 1, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 35, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://quantum-si.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20240509to20240509", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20028707_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20240509to20240509", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20028707_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityListingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsLineItems", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityListingsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsTable", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Table]", "documentation": "Container for exchange listing information for an entity" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "qsi_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://quantum-si.com/20240509", "localname": "RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://quantum-si.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 18 0001140361-24-025182-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-24-025182-xbrl.zip M4$L#!!0 ( ):!J5AP"H/I,Q0 +Z2 1 968R,# R.#Y'Y(=(LS")W[_1FNH; M(F*6\#"^?/_FX+QS?/SFW_N_[/5RJ 95XZP]]M,H?-_HY?F@W6J-1J,FWFDF MZ65+5U6C%<993F,F&F7]*(R_75$=BWV:S:J/5^J/#%E;\SRO)4MG5;.PKB(\ M5FO]]>7S.>N)/E66Z<'N^;QAE1J[511.JX998NJ:<]5@BQK3!EF:SRH'-/-E M1;@)E75C]M3QN@=JR#T8H?CK0_?SO'I>7W]>M96G-,Z").W3'.81>U,555E@=9!EP<) N5AB\[1'*%BH MR))AG*>3^LIEX6*#89J"F*YK498N$I.G2CX9B*R>F5#SD!XBRB$!Q&M;6BE-3T14X) MCDD1WX?AC_>-3A+GT+%R 8+2(*RX>M_(Q3AOR3&V0%6VBC'^LN7(1]D9$3,2+=I$_C-^^(+,_"_Q-MHJF#_!W!9RHT"B_C M-HE$ '=8$B5IF_RJRG_OB$_9M\L4%@=7ID6!_/<.6+W'PQ\DY.\;A^=G'T-< MV_\).1=Q8TH0#[-!1(&8.(D%M-@+QVTD7*3%3UE;_H0*)\#O-&0DIGUL*L+V M 4P QTGX&-'+ANSI(V7YWYK*J.HQPV6&9UJF\!W+9;9G>X%IPC30DFOCO(OR MQZ82E"=S62K4S_L&J*QV$(X%![Y%8!_VY9^]U@))ZRD\BD&P)AT@,:71<X;CJ8*[WI*]V$:-%>S34-;H:JUR,-4 M! )5DLCV]]""M3-IF^#11%JT=B_%7F"M*=/'-\<9;Y2EJ)C>-[*P/X@$R)A\ M>O61\C)+AJF\D@:Z75(O!UQ+?5E/2#Y-KT*.UT$H4B))%+46HW/\:7'TRXWW MI[<6GSX YB1\>@5F.(D-#_*#N&P@ MSD 70#U-L]0SDU'X-5SU@R6XMZN54QL2VPSX 1 &3@C[UL0.,% MJ%"! HU]LM?""LNM"I#22Z<-_22%9Y<6G117BI_D>=*'1PW&)$NBD!,_ N P M*\^309N8RX4]@0!)$C">(X\27ER!/!9@"\"X7*3O2)^FEV&L((II$SK,D]FM MM.A%WD/L) SJZNB>7O:>7_HZZ2_"_MR64VA!JF0BUY(U1.6(_B3BP M_.O)\<71(3F_.+@X.I_S?4;@VADSU\S8XP[G_*CSM7M\<7QT3@Y.#LG17YW_ M')S\?D0ZIU^^')^?'Y^>;)E2?1VE?]*L!V@^3^)=N M7DW74EDWM,J$7KU2]_RTM3]S-1Y'"-QUK/UXVOU"UN+EJ5=5^#9SF$RM0..& M;;O4-T7 7,JH&\!D5_FTBH]?Y_-&[F#=?,*2[AZ=7)#NT=EI M]^*I4'4V3#,,$X#[3LX%PS@2T0QRVB6:M4\\%6J!PF$:YB&T/1JS M'HW!_S]@.5*I>8;Y*JI+!;\ M;9NL#FUICJY566<2?QT5J*RBN_0 M);. MORA6GXNJ=QZ@26X?JV;@>.?<-@ M!(>G*X!?\QZ2H' Z428P+$7$C?TO=$*\71E*6M5UU\S&U=-9 S[F$ST'?U/$ MIE4DC$F89P24*RSX].U#2,F3 M6@9W7>$Y.L] 1!3!4!GNPS409<'U@'(^O2Z(DS]O&V(>A3SOX87ZWS-W$/@2 MT4$&=::_-@A%-^8::1YFQY][>;I?N5,6[^5\2G-)@F$ !3]$FH>,1M.NP#.M MD[J%YSVDK-],(1S'+$G!ILF-,QE&Z13[5IV$5_6#J6N&'KA,,SUJ,M?R ]\P M 51SUU==QOG-;!+NZ6'D(A>#-/F!-*$Q.A01'=%T-5:^@!(6A&_Q5LXWFS;S MV4_;QS 24(8AN>HFAJ<[ON%:Z'LRW::!X>K1S9NH[(/.$]%EI5_/H>QT*H8 MQW!,-1 F-U3'U 2GON78-A6>X3@\,#;PN_=UCWS M YX.CFCZ3=RF(8_;@MH MGCXC._#S-+U(1G&%C=1FODH-2Q?"-4U+\TQ'IYJP'-5P#-W=!(9\ '<,X")? M9MSN$G_(^KCP IW22)RF9P V0YE2-R/65P'#>CI,O>^;S # 9/B.(0S5]7Q# MPM:[X]I.$L<8463#?$U ^2KMM79MZAO;HX6UNBI\&_=8JPV*G;I:5W2IXUL' MS!;F\BP!!D?_&PZ6/!2F>\*V'5 M[OQ]8JOUNO:Q;&_)<<11@Q063CB@$1%C 8(,6@UN@R46V9T Q^9"?.^"^ZBL M!?DE*,#WC5]N&YS=PICGL<:+?KC=7GQ.0S#-DQ8H7R3W;,7RFV4RHIJ,9OJ:#+\E-9@)" 8]R UIL MUU4<0#/$\[^"/@#?*,BGIU*. *7M-#=L*("4FP0@E)$ M\$,BFDTWLFJBVEN@F*Q310N_J_DT3SU07GWZ/\,,7-3)PW-K>R1T>H)]P^UO M0@< ; $+8,S%3\;$%U$R0A'#0A1$XBJ?2!!&J,'##-1Y+F(ND^)!^OK#**>Q M2(99-"$9^/!9,)$MRP:)#_33:>@&"RJ;,S"K*-;Q!,IF.D V!G\X&6%[!-TA MQD.R=MWVX_6;-G=57SA3BSUO'#9@F&E8Y+U_AB%?8*-[BB#<)$RP$"BHAZ]K M45:1PE.+YNY)$->:SS_3, =)PXC8,"[#0UDU'4C7P!M5A6M8GNGY+O4,H=IZ MX'"=JD*(6[AY?I)$/@71RV$A-/9_^]5S3//=JH5=AJAKV5?HG%KVU9CA54^X MH@SNB=TE5X$W5;:20255ICL$V39UJUR>N!XKN2F8DK*C.:3SL4MT0VU"Q3K MNP;)U_A2Y8\EX/NZR+:RR,X3F<@,S/P"^A^,0%0-I'#7=2W-MKCJF]QS/%@V M7)49+$*W&'M=876\GK,4P$;!T]7EI9E4T?3*"EM(^9JM+U-M%C5?E]BS76)G MJ4 ;AN]'R:16!$_I:1 L.(2^*TPGL%3-TZEI"^YJIN9250_TP/"%<%Z76AW/ M@;4*J_#V6JNFF5S1=_RWFRV\HN[KTGLI2^\XRX8BK5^ EJ];FJ/Z.G,],S H M99;IV8ZGZY8IF*&_+L#[68"&4,P=MMD"+.L^T *\*B3V(([^LJN_)1HJV+UP MO44*SON@+C=>JL;238?9:-^(WB<41EP32'SN^_UWT<*VT_2NVNI;>D=/G[V& M5R-^5^7%;#&7ZP)/:R@2^EFOL)0;:HKUMNH*#FVR>W6SSNHVRI[S?*045U#M M'&R1C/-)'W[MU.YA/F%A<.\L#%N=^VNW3LI4?%R;6Y>(ZX@34\B1Q$^.ME$O M!&TVM]2W!S_W9"$VRX=\"#!S5=RJ #433?>E&5@\3<5R7-5V79V!3XU(WC(U M7W6$3]U O?[9]TI&9;>[A<,TPIZG M-S$%<-HWRB3!!"YIKA#$U=LX^12:$_#+R]8"\I63Q5@ MY4RF638@)OZ]-HG)^U@6 _^?'&B]E),*[4#D*P $)4; MF*JGN4Z@68;EZ [(%C.?GW9]JM9[P[#W]=F8FX5_[SLW[3CFN(,@B#\A3.:I M]?&]FU%/R/ZY7Z;)*.^AJ1I@8AG-"!=!&!=O_Q>I+:HU M#7(OY;441ZT89.>W7S7;>2?36V3E"F_S7BA/$!C@"0*8G%GL:^B^HM<\M>XD ME]GC<8]CWJ[RV.;+"[RO&8#,P[PWP3E:(P37O(4R;?:[;-4I&E5?0_$UDVL^ M9X[-3#5@ONKJ5F#XU+.I:XC;O"B_Z=[@3R(&]ZY!@BMT KZ14*M@PI4$U1ZH M#Q$)AD<[QXG<+!L"RL5:0'V9!HL'E8=R ZTX?5'B9^PKFF#GHS#O53B#\A@# M\5 G%3]"/%T:U!.-&>8)42:/&,=F>%(\IRG/BA18OF[/SMBALSV[JK9IDIE0 MK9^#VUB A6G>\,C'E5,=JT<^KIP'^3A'/M;RJ:O<.C@$<$[VI MZLT'RBJYJ<=Q;YMZ79$-HUR^MG@*6K9,+P$-23[.E&+N8736?Q]DB:Y>3[4![410I#"_X3 MZQ%#*ZA9,*F\-)+R)4/B3U_7'P[PH+RFC%P-)E,KN4@(P.Y@F,9AUD,J$;'W M0C_,B>.WZOTH ,T.@]O,88811*"^8*@IU^\?^3/Q X_LL%+H9-2!&!ID&1"JHP96')+&:AP MZ!IG;1=E@O8+":S*>;7R5-AW9X?6C# 8F@W]?Z!G)!0;1B'UPZCH2I)!P"M&5B M((_.$V.Y6/#5+I$C6P%% Q7EB7ILD9QLB/'@DJ(KU\R-8>?/A!S41T,.7E/5 M7AIPF,.#6>RPP VE?LD>'BR\2OMCI8;7'QS W[XT(=^>+#]/M//39OTZZW:. M-DPO'?7"7"C(-(&1G5%*:\Y7>WF_L8^.ZUZ+UIT']V+F>BOI!FQ"XKYE,83M)8N7W@X.S2HCY"XC@$,3QIY$Y3=UT?;V* MTSH>=A(@B.#&'CE&ME,FCUH\I#DM#GG>P6PBC@%&W"N685*LBI_")OB]7,++ MK\L\_)NPMTH)>MTDO<=-TD=S61=XF MACVXOTV0ZC?(BN22[\,P+>.0F^6+[=9EI?!A-"&,#N77R7%7I3C]K]P4R6!X M@E<8DQ1?OO%%CT8!AO#QD7+3H*@J=[J&,;26#Z;#O)>D, [^&''\IQ"(6?]F MY1V"^^K#YPQO>'HTC+(XQ%E_/"]][<>E'@Q;58ZNWN;4U'1[BVG:EE^].2M( MN6BKD:&[0SCKCMUO!=-]F+3OBHO-S0=Z[^]_WV7HK:Q%_D<$03HAG\1DB[[0 M-M3G365P2SS'%RFV*'!;&M6K%&V7W_)MQY*()*D.94?L,@_V M'AXR2/<@;:NAER=UH/_26?&U'R2H_.+7?_IW.;:TU_(3/MF'O[V\'^W_/U!+ M P04 " "6@:E8JF;J1'\M #<3@, %0 &5F,C P,C@W,#=?97@Y.2TQ M+FAT;>U]:W?;MM+N][/6^0\X:O9NNA;EZGZ)G:Q7L9W6[TYLUW;>GO,1(D&) M-46JO-A1?_V9 4B*NMFR94D A>SN1*)X 08S#YX9S( GPVCD?OK?_XN0DR&C M%O\$GR,GVXS)2:QS5CZI'S5JMD;O^U!]/ F6R:.^O28-/^KXU(?V!Z;M^\+'TD\W_E$@835SVL63[7E2VZ!'WM6>?ZG?*_$+8_) MB 8#QRMC)S\0&D=^=B@0#Q''^GY@,;B7YWLLZ?Q,\\67M('Y!_';)")^R1#P M X])3_N^:ZT2Z/F/H=-W(M+M'E5/?EVG26)$M];^$5,OBD?E6X?/3OGZKMQC&Y\,(HX#@J<[]N&+5M)QB%HF/_ MC]&%T?DM=BSXR%9W8TWLW)5=P9.>1/:U[K>.\#[?]"Z_7-V<&: 0GG<$\QIY M__G[[<7E^>TM^?/BYOP7\N^?.K5J]9A\HQ/2-81HX;1D%MFLG2ND'.?M[\(S M_0!,$.?QDU_C3VL]> 4NOK^DH47__D#^N+WXA;S'KM4JQ].'&?P(=#;]Y?8B M/>(')!JR] AY,NR:8N)VI?B" "6X@VF]S%/L[03'F67#V-QJ _=>K8G"/4@&K8BSK:_LU M2",$K'89#1GY'2YP\:(EL/UI.G(G$>T#4329ZX9CBJ/ZL50I\>]C:EG9=Y>& MXWUEZ].&-WA127B6!]+_[0[K-FR+-KO-.U&J]/JU^K,K%6;M6K#;#5, M]GJ:^.A8T1"_5/Z5D2+Q)_\9^Q"LU#E0M]E+Q076$UQJV3W2MG17*\3\0YY3 M!'[$ 17U8%S+U0[>>88NBD,[!M?2IW__U&VUN\=+[23KV:^1M:Y416^?$JK@ MP"I+%>=IY%$ -P%[8%[,D'"\:S3;!E!! JBYB$YP @+22^4,AX(5M@ _H5T^ M 4MO:OBU>K-E5RJT4^U;C7ZCU;5HU>I4VJTF&'[=;FC#ETE%M>%OQ_"YJ\%I MB8-$!$FZ.?4^W,S[P%]3#^0-69)P9@13 IQ)71I"(PXY0('@X8NRQ#^"&*F- M0:U.LV);==IE-=J@=JU?KW:;3;-9:U19N];5Y$,J:]$8M!T,N@)^$5#S'CJ6 M(@YT.71\C]13[ DSMXW<.Y%!'H<.G.:$A/T8,Q.92W^2@PSR1WTY:JB-%U5: M;53Z+;/=[)L-FW8ZW6Z]P\QVU[:[E+*FQ@N9-%OCQ7;PHI>%4M!J(L0)C(_2 MV*7DS'^T)@@DB 6??1IP-#AS @ )/PC5-7W3[-)FIU&M]+OM1KO?[K0! O!PBGQX+XI;<@ME^2=E6S)LX?_6R*M MUSLOR]E&SZ/N) 26)5P\0 '/?!',-= JZ/ MAVG 2NYFX)G"%47R.6 >PS51$"2CP$>3'I5]L(]RVKTTU#X(_$?H( WQ'B,X M!=<#'Y&YINN" 0.I)+U!C4O:F[3ZPIOR8'AV*@"0!1?IL[U?&M_G':)NZ$]E M$3(S#F8&:H#]\43 #MSN\9 &(Q!.'$8P3$&8BO7/(29S49-:;.28V!O&8W>/ MCHMKH",*#:#P7X11@,@! 8 IWS,P0S;@-T_E8(I56M&V 5N.NCZT[X?BX!A MIA_)&2%C0BGP5V *2!)F;Q[RIN.U8S^"[R@C^#:!AHVQI>+Q4RG (,,%J73S M(4O+'_,QP/O%D>,Z_P@U3,4;1R"^;!$[I(Y%_IO9-OF=/M[#?0R"*Z".E4KS M=.@PFXC$$)3)%0"/*:QBNB9^] +CW31OX>F,M==1B)!GE[:W!D?)"'"S M!HM@EI&F$ER)L;OY-QV-C\\$W!@9*HQ HQ-@&@?^@"]@PX#/!*]02V:#5WQT M'UGV-#3:*718S(71!LW";U/A<.46BCL?Z!*) ?X3K]@ 9X-1O30.@]?\340,1!S-(0,677U#S!L"/TUAH2NC!=DMTH?_ MC@D8/P 00K2]@>OWZ0R,XH %#JZ<&+PO(8R?8R/UP18+L8TCCK/WGO\(,\6 MI4C@.C:(V^17A\FHAOCC^;?SGB%@L<]PW";D@;HQI^XTG)F5LF'BG5P/Z(\2 M[%&'/:R=/"+R_Q8QZ"D&_%RVX-;1:#N W,LOG:U>N#?X3TG>4XZ&8;!]2F_R M=/3Y=<$-9H+M+"F^3"%R8&4@9O@!Q[=E*1$I(TF$FJ+&;X$/)@FV:0-\/P*C M>U=K=?D%B!$#_'66\PN?A9_:[/[KB&>J(;#X%A E?GYZ"J>3^?4.0"T$"1HX M'!\2;/'0(8$6C9!/YD?XT0_N\4C@QP.!BH(HNB >.@!10/>F(YQR%TY* 5>2 MFT7.""6"G1DY/_ 2Z*L5P\P54A?NT6?1(V->3I""7H%"A?$(VSG;?9@BPFE* MFUJ9;=NQWCL_@B'QQ^@^H*AQN+V0X3# _/BN5C]J@>A=-T\LEYLW)\L!5Y2\ MT-_5ND?U[!:I'H=TE"I>>MLQ? F$NT%ZUE] ZOF]GFY>]:C[\N;!=8U?X#S=R"A-SA&:GA)"1& MV H\.?.>!$"CAX6.+DU'8(GLG12[09QP2W@89Q-I&_#!O_'/O7SO@;%X0'1A M$! %W D,C1T"O>2$ FX98&C5$J?AXW!8Y&)GHS8F1E^^;=>[SH7%1X!U,7@L1E3*%\YF7+G.#U+=!D\Z1QUA,GCP>%L'8"51 D! M3!D\=L!!&HK^8;)&]D2@2#)>M-]<@#R^"50A1[::1XU4+Q02X-I>\XLKL;8VNG@?^:C9_65M_%I;7 M7K!ZV#ZJ+2X?ML3!9_G5C0@.+%OD6[;$IZ#(UBP6R;O&42V% MSK6$L[#Z^>8*)[LJ/>MD[T;)]J4^7Y&M1. , ^&LU"73G6* E0@N<5H4A^ , M:=1*46M&^2J;*-^4/G#WXO;5M"K\B.+%+ M1O\GZX.XDP0"W[/!C\'A.,40XH5G^\&(#]B\8JL0&<_M.L#'>8BQ6)Z*D_82 M%U_Y$KH3FG&8N \S<8!9%V+6L--B?%#GNV$5H3"T+?PS4Q&);K MBTL<#1XU-YTQ7Y03\L41@>YX!#$)[FQE Y"(%CV%*%O=IP_4<3G@86 ]8&,7 M!E/XL>DH\@N6[_BP,7K-X]<.(&M+R]T\]RM5VPWL<&$WDV?%OK69-[?GR8J] M2W)!KT:G=HS10;%&@BM$'BY9^VZ,QN;\DVH3IAGR=1R'N5:R=!LQ?^28H5AW M3F[Y,P!$C':/:LO,H0=-'.!L[,RL78]]#)+QLCLJ4+;LVV6 W/*]@_DPF.KG M>[@>A>M&0V=,+!:"J$3LE7E<]3V48)(LB3P"-X)S67GDNT "7"::"!W/)2[Q M91]G 3A'S;MPC2I$,[F$18>@;8>.!NQ@GC 9P6?+Q:)6]"!!S,(]!ZL<>+S MY2< ^&R]:NR'H8-MY.MA9Y>S:V=9>X[(5W@N$!B^GA4A7OV=C%[H')G^"%$' M]Z<1I@V\&\<'SOKJ>/?,NO#2W^'0_\7/1^H;^HI6?1>5&I=I;'P:>/R6Q,;W M8FQW"[%RDB1^AL_%\M,LP6_#4BOI_F9G%+Y,O,%D]DWQ>9[ M'_U(LPL'OF_Q.=.!&V#FO1<9,Z88^>9]N<_7JE%2<)?I>CMRJ0 @*.9+[B:( M-5R2*&G,+[80.PYXZJ-H!IL2,X-$] =VT<+L8%.L^L#U8/Y1DC,#OR=S) M@18Q QA4P!+^(%J5?!EP9PH/H>09AX:EGI"1Y28 O-D@AKP$,$606]8C#0* M'F!_M.^XPH7"FXLT3M$8A)I$ULHAS0H"D/+]W/H;YA5@%L3C<())&G3 \RM0 M@1T@5>'47QWG>"E>_)0))8YE"!C.[!AS0C)_2N3=)_PZ/S; 76FP.ALA>PA. ME4Y>;84K8N?2+'"*STP1S#*WLV4M=1#F'W :!P%V7&SO@^KU!9I,.N7_$-Q@ MU9JFR-Y.O6YLP?D/H7!\*T)'R/9];HNUV_/3='LUO&O.37I2JY[=.?45ON:L M9[*.FJY(-=]1WL(;9B[(G[L@#_OXDM34?/7]>[3'6S!ZD74E"^M(C#LDI:3^ MI^PF;0VSMI:XQ:;9:(QRCS\!O5)(;4SH#V!D2P*M0@X_?/5XLPSL>@D_A M/*#W.C7\O&9]A2,# 6TW#&&.]$SNR.*6RX(B4)A64T^P(XP(3/R;AT(]=#$5' M*+,)\=.JGM7R0J $*5M.DG?BQ'UL#QC]! QBZ^O@99N D,H#?D#A ;_!"EWKX+T@&_T%.@_^:V"?\ M('K'[YM,4^)QO/'B'7SAM%%T0?ALO3W+LB;A\M=RYBCP],HFZBS(-].%=Z$*4 M4*AHQA_-*XZ8LJ"%:<%,,IXP3_+IF&<$\-3 :=6*2$&>SVV>9B_/J#Z7)@L> M'!-5T^'QZG1$DV!V$ECF<>PH7):3D.WH.9.]L)94P'.'H4)7F=>30/,#)[P7 MTS*6O@<8@N<3-6&]YN?!;:P0Y27W'!U@:'$*K:Y(4Q*"D1J$YR%C7+ Q^=#F"CY$?F2W(?W M#"%$](LKF^B&J)G)=*H.W0TS@^I-L/"_RVP4-Y@4^Z=I%$AX-17WDS-9B MLPT^Q=F7]+C>8&0"W0P1&V9$;%0+2(K'OG'"?BR$GSQP#@RQ(C1 UPGSYCD= M38L^1:D L/U)0OQX&U&I[MF$L-'8]2>,A<=+V9WO#7SL!DP?,).'&&.)P $( M.9&$:W(^ QV/75 F]"I<^H@FC]0T=H5-'<^+874_ NK@> N-SRHK$R,4S831 M@C%"G\5/5B*2LH'9N_T<9CG0S]LJKPOEL]1Q6@DZ?P;/F4M*,&>?E F,_4@& M/K7[K/8S:7->#KBIA#?)VC@_N?G64) M& E6E"@E9X$&21YE(%+$"*PXN_%)*08CABX, B90^(G&\TA(E 0OQ5")XFF< M-TSA%;J3)-C ;1/WFQ[0P13]\T8YD_J_9/ZN.WF='/"AOR#YH&<--B M4-YOCCPBBL0+5'F-+5+);*85^I*V'H;>CX/DV5Y>+ DD8; X*<'BL)O9:&*+ M:1%F.F\O8%0XQPO2N3\G<]YC,:VF]YO!DT4+ 1+L\+&AKN]QY4*1T"#R$CB? M#M_"8&?T.1=C2*EM%HA+#B05;$96SA(PKL/3 BV/,4OT/J?6&=1AT=&DW+>GN?%O%YS M)K91K93_PUN2E'>"EB^>\4>2@S#7+]%X&T;4&X2YV,CYZ6Q4%%B)0)4LCH0. M0#(9.X(8I90(W#P@)[,$&\@+EA6ON&D@IG/.:9 ,0VOP6?$,BK/#MZ+\[UW>??]6_GV@EQTW\/3J\NS\\O;\ MC,"GVZNO%V?8/O*Y][5W>7I.;G\_/[^[W4US^0VG+[19WM[W?(;PXQ!F"XQ8 M_> X".J9,#*8JI/5%SH"I8K"7V1J_'>/QA9ZQ$^VZ@T6>EY5*)'@@FE'46Z7 MN;K-:*52I9VZ66E4K':GTS(;U9;=MBM=J]VN;?&E;2OWH7L^L?@A*?40.%I: M2):%)X$HX(3I+IUK9U\G,LLP.H]KS\P/O'D+QU8D^#[;AVR\!G$$NHOCN;1G M"SU8U=47]"R_W]5KVY^VM/;R,4@FF5Q#2>B[CK7EY.3U@37+@UVQV=RNVB%V MUUX[J7Q]G;.]]?7M^5T)]Z2!VH+DM: S\"EYQJ<41E0_0"-:LXCGN>Z^5#.7 MM71ER4HC7[+R]H4\[;7J>):FUO;"D"TN9;^)VKP56FTBZ;T!U_X:O66SE:!C M6K&T8JW5,8FF!JE /TWOHQS\/RB'_I*9GX*&I006ZV'>VC#O"1F34%F[]:\U MH5VV2OC35<7)4F-H&J'<4.IOI/Z81K - WBC7CZE6\_JQ[NMZ($7CS97@B6O M,DG?6K)/B37K1K6E4MQ"+F/2$*$AHN@04:W7C4ZKHC%BVNE]DS?):-FW9<6/ MJE RU9%TJ^W? :YM [$Z-:/6ZJB)6*KQ%6T_Q;.?&LSX[=8!V(\$<[F2@9B> M:?+,N60_)ISZ#;X7!19LX(XIX@U/-GDGWJ'RKF*DQ7]\QRA5R(%VQG;4RR([ M4+5&34THE4 OM$VK.W9%MNFZJNZ%#HCL@![AIIT>%L)R4J0*V5$=\E0'LRW M5,/H-@[!C]/6([>\U;2>.EA/\P"L1X()?#U:\H*D];W-_=?X+FW'FMVF,]G+ M82;Q3Q5:\.9#HPXFKM?U]:IDE ?8'0AC0[1N-Q7E.K*:F$83C28'BB8-H]:J M:C21G#;NAOO5FB][4Y>2-$]U=%4=$+>R\-0PZNU#\&"U_<@M;T7MI]4RZE5% M,U]5F\IERH-9K[@38SWXHH=([ *,Y4A\WTVE%GTD6">6QO52'0+W5R+0,JJM MKIHX*8%J:+-6=^P*;M8U5=T'G>>R??ISX?&7P.*[*9)MQYE%0M^.'FGPDK>4 M:[]-^VUO&KOM*KH.I!K+T+93.-MIUA5-5E=M*E[8%=JL&T:CKNM[-UG:8^+O MVMQ(O!),*1)4S#2[ TF@VUMJ7*NK:$RX$ FTVF:US6J;58N^O"XCM[$[DO/" M#%>U6,Z;2U\A7'U-ECV^LM'R8]S.;^NX5/#M./H%3MTOKG);I>Y1OY8H6RCI6_2^>K0ON/R[89Y"G88^>;]$'YC M0?@S3\B.E-EJ4'4P5]TWWVK[YYTVI7[[75R M+9E+XU&I#EX2]%(2'T.U:5^"7FDKU%9XX-DTNR$:+W^9P)A.\$T"JE *U6%* M!TRW^Q85H]IJJ!G@5(U6:$O4EOBD);9;AU 1* &UD"G2\1("$L3LR2U[B)!/Q<^UH2^%J;E8,:U:ZNA-!6K:VZ2%;=,6KMMK;J::?W39M4>+%!NOHS M]J&#OH=O=_3GZL$59$FZG$)A_-Q;.475:*FZ+Z@N@M)6>[!6VU0U#G1 95"[ MH3VOW--?088C@2^E/4;5/<:VT6TKNC&8!)JAK5K=L2NR55?!CZGH?;MSG=XW M19(I![CTZ4\:!%1-UJ,Z\JF.:5M JVY3T6IFU;B%MIW"V4[5J+4/(1E-@BE< MIBC':S?V57#"E\!5T Z1\@Y1S>BTZVKBI 2JH+HZ$?0#/Z DZD5$4N+R M^7GB4FN_%6_I&MUZVVA.;R18R2*!>3U-48:82.!O:-]1 M]QLW5:->%< JW0 M%JWNV&F+/@2+EF"A2R["UK,L!S>,I2ZP,\>"FQ*3CIV(NJIP'M6Q3W54VP)> MM5L=HZ/JSO:J,0QM/P6TG[91JRNZ=9AJ\[F*89J>:<:CV*41RUZEXX_& 1LR M+W0>&'']4)><2(5R$O2RR![2^_H![BNRD<1^T?B@\>%@\*%\>.@@+^-28'N2 M/,&RF.V83J0*7NH]#A3&Q[WMN)]*J'!MUIN/1>%@6P)AR /N^TLU:-:-=EO171YD M-3*-)QI/#A5/VO@V5T67,G=E9!)RQ<;N8G+UQFMWU>/9WD5BA4](75E\ACX1 MRX_[+MN^ _MN*P._>QC?IH-2N'B@)S M#"S]!(3?OXYL^*>^Y9[ENDR&O"N#S/R%/GC],G) MD;3[_& V )]OKK]%:9VH!Q'PAU'^DD7'&K M684[&0:@ >&06@Q5@'_(1EFT3RAT!<'IU>79^>7M^1N#3[=77BS-L'[F]@W^^G5_>W9*K M+^3J^AR:?0$GD-XEGOGM^N;\=[CLXG_.R=>KV]O=](??\ /!X@?'7-6A]XY' MHJ$?A^ [A 9A/TPVCLB8!:+\E- 1Z%84+@3Y]]GD[QZ-+2=BEDRM(B^ ,HZB M!&7LDV$2V+X*&3:!@9XW\J9ZJ^U*V]5;Y^PJFJ^K@BOWJL+5??EZ:Q.% M6Q8\.*9N$\27E1;1M1E69;32C2416)Y:FF+=2:*F5C*!P) M*88O44RWH9C^0&$71O<[-]'<)*/LU \C?&V;Y'[P MMM)-58D?RHQ9^]L?K]I1-(%A^^JL;5#;X&YLL%Z0(G5EDMFUWZ\]%.VA%&SD MM%7).S;:JF0=.0EF8$7]_M\"/PS)./#MC=ZDH1T.[7#LV.&HM8J>!"@3B= V MJ&UPB=.OU"X+VNG?>S5[Z=/5F 4T MD3]F/,O)"%'V3E'=IQTHZ33*"EPQ': MJK15*3!RDG*#E\[ZS\439@E !S>W_73#0L8WO<-7 %CL@;G^> 2T0:4Y7C6< M40U!-G8ZC&KE$"JKM3EH%!]D#) MUO(V7A0]J;5Y]$3L1> O+)$H3\4*BJ(%Q<=-,S/J1JOP.S0I27FT&1Z2&7:- M>J,@[P_5^1E[S!']BBFB=N"/4F;B>](RDF(Z>L7TX/;FFKT'AE)O*5JOMC>I M+;SD4-N\K..L;7Z)S7>-6JU R\82V;RD7&N/6:YGSH,#]['XLIJ#;P9C800? M3'\D[;J::@ZC:I[@%ER\NM%L*YJ!+WM,15N#,C!-)W)8:!"/*96EJCT<=8!M)UR]7!SH4R_K1%NHMM U"$JW M4=-6.NVTC#1FCP3E=$B] 2/ 4FSJ!-CSF.&FG(\T"*@7$=>A?).P4O=O P-,QIF9("9IJ["V48@1LJJFSJ#$SJ^!Y<%"<4C$?TA;R!&UP04$C W95S5KM%0-67DC4#C B5MNE# MLFFLMZLJ&K>2RZ9U8.P-^=/U-CC3:E4MG .[NJMRH_2.A2$WMNO,'_7,2R.) M1A*-)!I)E%@X;4@7.5M:0W[)(N+ZH;+4[PDQ*PO%T"=B^3'FP6_=27VWE8'? M/6+O4F:%"M:]$J>V&JS3B*(1Y; 0I4BAPOTBRMLNFJ;=W5K1G;RNL02]*E(E MS5ZA38)>JE@)HZU06Z&VPGV/Y![2H'83MUG[I1!ID(:,60!M&XU\CX1#&C!" MHRAP^K$HFH_\[,?(-^^'O@M\-C1 _*%CBA<_.6X<,4L5UTQU+TQ[5ULM"GI? M.:HJ&H4YY("+MFIMU<]8M:+U)P4)>BBWT]#:1.I/OOC%K#*%/M,!$RPJ)''( MK(0^C8$@88W@E'#MB6D5PZW<.S*K7\:SMZ2#:J-JM-OUXF"QWKY(VVDA[;1B MU#H'N&WZ7K*!7KTDI%J867V?3.W0L-I!7ZWMBLI;:WO!MO21R5-OOSY35>SG M@QYZP(;,"YT'QGWT#RK'/?52KE[*50GG=$*%MD)MA8I;H:2<9(\ET9A@$7L! M@_O_PRP1^G_RA02X^V]$?Z@4WE2*[JPE65J$ME%MH]NR M444K>E4+?A1GVY8O?L#@S@1-G7GFA$0!]4*7O_:94.NO.(Q&\!A9X4YO.JHW M'95A)X7W336!5^]MK&%&PXPR,*,HO3O@#5MDW.KXSH^H2_P5*U\J1*+TUJB% MQ-!-25A=T:Q2N;9%U?:L[5D*>RXZVU&)QZS>]1(MS6D.X@=^R1"NCFF MG7Z"PYB?E?UR,GNKA8;D9;>=Y1^FG"O^S3%>R MG_*2 @G/R_0)&>?UVP0?@P5K>A+Y@5YT+5:,_1_?>Y=WW[^5;R_(Q>7IUG)]>79Y>?+WHW5U<79*K+^3[T>T1^:W7NR9W5^3RZK+,/W^Y MN.S!>;VOY-MY[_;[S?GM;OK ;_B!.!'.1Z*A'X?4L\(%Z]]GP[Y[ M-+:-&'HU*2]!?=&X7$9<7A(KF!VB/@=MM16L7N$O:QM;+);NUJ.6KS70N"'4W M#!@C(_AE&!+F6_<]&HOW[% >M.K56HJ M;?"WLS'7VBJIMJJTK%V(U:^U A0[2NO98*%+M=*[6U*N L=M]R4Q MI=_)M#>I*;/(I/%&XXU<>*/R^H_D>",!K92>,/:R@K\0=R,.F.E[IB.V)C[_ M?'%WUE-Z7R254'NK[=>[L>F]![6V:VV7K_Q^99Q.UO#,VE579\Z# _>Q^$;^ M#L8#61C!!],?,54F5>TP[:B7A79RZD93QU1T3$5#A(:(E7$0HU;M:HA0+@RR M%GU3H4;^C(T#9CK)/DC(VD8^=/4??D 5+-Y]YD"ARFQEJE788=EMU:BT% U! MJYLJHZU66^U&5MNIJ)0EI%"YO'(1J0W6?\0:CRKT1@(G3+N:ZKN:5:/;4;2X M7')?4V.$QHAB8$33J-0T1A0T'B4]+7LJ+4?\QBR=GZ,S%G3&@JPQ':WM6MMU M?H[4^3F_4<=[^O5=1=/-5";1"6[2Z8U=DBWY?,[J-VN&9 MM0YB+._[5MG4Z9!Z T: 4MG4";#G,<.72CS2(*!>1%R']AV7B*'DH9G*,"C72-RR,@MB, MX@!:"HT+(V76L!J:Q1&/)@6))IZJQ M1/873ZS]#LV7TKZ7EQW-D<(.-#6M1,JJC52A>R\0JT+@N\';; ]V9_?]R0P MRV@V%%UU>R-<*DX.DD84C2C[1Y2ZT>IJ1-GM>\!7BF%YX_,ODWS#]^?V:ZS; MIM3N]RNUAMWI]LU6NUMIP@'6[K:H5:CWYZZ,J^KWY^KWY^KWY^YE24._3_=5 MIEC$-Y02_4)=K:[JJ*M^H:Y^H>ZK(J) .OR(NL0?LX!&N.:=5!$4;-E;^3"& M?N&E*BG+&,&H*9JV)X$Q:8C0$%%XB.@:]4930\2TTZ\A<_(7'VQ[?\QH!7?; M9,=,V=.L54NKEB"-NI![ FKMU=JKKO8JD[0O67Z^ZE5ZVA711=&;)TDH7!@H M>5VTA@@-$86 "(6K'R6'" FHFZZDU&^KW# 1MK 52WNK17JO;&'C&\%)<2B8 M!@ - *\ &6K$>4" D)%L_DERE@5FMNNK3TQ/*1JC"]\2@I"^8K2W1T4L"V MBI_VESQ0-3KM(E5(26"Q&IPT.&EP>@MP:A@MI0HG]F"QKRC,?&ZDGBKBG"]6 MFJO8G/TV.VYOL/]&?E26;,BQO&/D!$^=Z5!ZF><'(^K".:=PE)H85,3?G^SC M_CIRX3VP,/(#DK1VR^U:WHC_9K9-_L,F^,K'TZ'#;/+%\:AG.D#^KVS;,5FP MEW:=Q)^_QI^>:LPK*I3ET89OS'+H7E7A/Q3?%.%X MC/2B>\<+?<\@M_]SC6^Q.O5'(Z! J!3?^.M" 0KWI18C%-3N-6/N6QZ#GK]9 M@D/9UV$ 6!4.J<5P,N,?2B29[$2I5S9]#1/=R8==LLKTQ0DH^VE9]=A,E(#& MD9\="L1#Q#%!)!!./88=R7J>^[2 P<]+=RJ%DU_[OC7A'X;1R(4/_Q]02P,$ M% @ EH&I6#O:Q7ZR!@ EA0 !4 !E9C(P,#(X-S W7V5X.3DM,BYH M=&W-6&UOVS80_CY@_^'F &L'V$[C9L/RT@!]VU!@W;JNPSY3TMGB*I$>225Q M?_V>(RE;<9PYV3!L^1)9(N^>>WCWW$GG=6B;B\\_(SJO657Q"M=!AX8OS@_3 M_WSSB\F$?M E&\\5!7M*+YQ5E=/5@M.*^/?*EEW+)E#I6 6L[+PVB\%:>O?^ MI[ENF&;'TZ?3H^G7L]GQ8/]+NUPYO:@#'9VG5%\ M[O4G/J6C)\MP1H&OPT0U>F%.J>$Y[D3+IW3P)/Z=C9+_2E_VS-2.C/6UJN O M7XPHFG@V E^!W1I.S1+;*1TOKV\9ID*5'Q?.=J::;#\:HDHFSZA5;J'-1$"> MDNJ"7=]RR4FZ5UA7,6P9:SB#OP$__>@!#AU%,]FW-A7S'&]< M93(*VU1 ]OJZUH4.='(RG9T?_@\!TGGA-ICNA; _JW\%SZ^>R<[I1VLFWS]_ M_HZ^TT:94JN&WK+RG6-_&^3%PV/XO?-!SU?_/(C1Q1M#JJITT-9 0FB^!@RL M71,\E:HINR8*A\;:LD3R8@G3E0XU_3K]94H+-NQ4TZSD,2]EJ:SK3!"A63H- MB\L&4!Y_>?#M;/;D3+B)ET=G7XUA=FY=JR*$$@"5-K+/9!(W4K0!UV8V$9"C MGSME0M=.?M'TQ@#>TKH(]W&HF;+'E[9=*K/JG=*5\E1I7S;6I\!D;5[TR ,S M>P\*&OCA&X;>Q2?OTY.UN2HZ?*M6=#).^JB, 0&E!-(S*5C%4J@=,[6(M/;$ M*!+9Z0\3DJ,EW!?(Q=($EQC$A3M\M MV6D)V(YWN?GKK!)P8U!8101[6$OU AR8-H'F),V MZ?M()4KE>-Y)8O.E:CIQ.-W+8+>#O!8'$>VM<5=Z'@\TP/CZDE ;<9@HB% M/7%&$B6/?4 T,""A#+#>L:]/Q+?*J$5D'#4 L7#X)26'5NVB<53?BKJE3;7I M&&4MQ$6S?2(47=B$#YEINDJ0[4&.P)&?4"3Q'A\$I\OH5'FO$4^&,:57C/WZ MWIP@7WH8:U6YH1C3!^O_Q2; N]K!SJ'H[_6"6X#'-_)8=%'Z9[67B2R7JI)> M%<=38=I"%53L"GR]E+G59PF-V;^]Y_6+-Q]>/9^.UGQVL0]!/OHZWUI12FH4,T$*1AESR)3=V*1%)!$C_EIUXU)]2 M[[-55P9).6]Q6Z**TH0'@6TK6>?YCXYCIQ@/]&(=%V*HX"H&""V2 ' U)&$O MQV.ZJC7Z"U_G EE86UUIM!$-=]J)'^A*L.7'2:%$.Z2,L37UY*2@/CA$TCDQ M7*+FUX7\6RWO#MMJ5ZM+SL<15DN.U:.AL#[Q5&,LQLU<(O,.AGEG^ 4W&AS' M@UC%^H(J#J.'7C;0'GW)?8%6:C4)=H)_Z;PR(8,2[OVDR$20(6-.Y!4LR/"P MT.686DB,GJQ8B83FJ0(])EH:QV.T79"2J'09DCQ#T"O?2SE:N#!A"U]V+C&4 M%L3GF]P<)-X6P.V,FU(JT6'\I4HSY^[B&??UM8?:E!M>CEL.2D9DG#B*7UU+ M_E2,,,O4'! >R KZ4_ZU,YF@5.@K1D00N82C[0PT%54A T-D/?]88-I+A&#J MD!(& KPS?>3$J&=P!_T5$$@:DY-F#DEH"[HA##GJ#:@*J07::SLT!52 J$T,7XM_6Z* M35E+.%CEAXF8:RHVL2@(R46%LW.KK2:QHTUL-XI_OS?(Y-!@\@A9$[;T+'U3 MV"^_VJ?"2"O7M[,R986(*R2;RK!=#9V3F8GB<%D-#WZC>IE6&7;@;8 9OPH< MH;SO2(=+(]*]@/U"+4].?6>OP+H4G6> M[P&RLG>HXPYB;U)YF[\(.\^M-5YR43THF\9>L;S%*$/[D&^/.O=ZLXWI.KHX MEP2\\<'HUIOWW=DKGP4.9#EGY@PY&@VOWJQSAKZ#5%3P69!&28" $Y%1OIP% MI0JQ(I0&;ZY__NGJES#\ !PDUI"A^0;]+@7.),V6@!Z?'A:4 1J,HF&41N/! M8-3:#D-+7ZNI(BO(,=)8+D'_@7-0!28P"U9:%],X_E9BKLL\5#0B(H\'R6"4 MC).)4<0@!Z[?"YF_@P4NF9X%!LSH@D(6(!,"5].U:@R]O+Q$+\-(R*4QDJ3Q M7Q_OGYUKC_VFZ(^]5E!&^=<=P^NY9-[T,+;;$-G@<5YL>F@'=Q2D@T5)\C\V&C7#8 +4,]:8 =5R'V8[M MMN4,PF08#E//-+FQ2UQ@-74+4:^8-7NB4W\+3[! [HRGUN L4#0OF#U M[:2L#")HVCH+_E+(2$R CU" M"@9G;L1NQX:B3#(Z8?=;O]X$EN3 RD$*&".B *FI"7J;0?$_%54&BZY1&0KE M]'\<$\/SKC$9"K!_-QQKYY,) -G!GT]WIZJ*T_-.D-+6L1N>W7)-]>;.9++, M728%B&:SX"RB<>V=;^_L.C%E+DE0B+R%]A#S#%7F4,O>5;QO9-]^J2![X-=N MO)_U-;N&G&,2S$C)+B#NIN1Q7KWJK\$7BGBO4E0+N_7$5A.3=$)JQ ]^1>UB MML2XJ&M9]0.[%\29J=#*U]BCG!B85G[%9O,P6JO,)])9#2<*]UD-^W [Z.&5 MB))KN>GBN4WQDSX*2BE-0])-0IO3S'J(@#59=1'0X-VHAV..*5%=/&\)U;"' M;T5)%\\>;@?=O.Y7[TE5+3DL;:=YW/T^C4FYPPJMG3 =A.FO_77HSAKT)?YW MCU,7LM/Q>[P;];N =NOYFL =QSJ_LBHX_H$-8%PQQK(3?OS?SU MGT#;RNW6R"5?1/N)T.F,/+XZ'_O Z'0TIYXF%WOO>SU'WV&GQ/R(Z>9J7TC] MQG9*9L$39&",SQE\QE*:5E;=8K+ZO!+-PNT:)*'*0LR[_('#\PI+>%B\95BI MF[ MQ--,Y)CR.PVY;2W->9=S99KHTI[V!RG*8A:X)_R4&DB .&7,ZID%6I8&C@U: MFF_ SRNL>5)0D7VJ7)6R[OWM-;@>M;K3Z[\!4$L#!!0 ( ):!J5@]+%QY M'@< %E& 4 <7-I+3(P,C0P-3 Y7V1E9BYX;6S5G-%2XS84AN\[TW=( MTVO')(&V,)O=25G88TK.1+8LF0[(1CG!H+U M^^C\^B195FS>?5C%4><'4(9),NKV>P?=#B0!"7$R'W67S$,LP+C[X?W//[W[ MQ?,^00(4<0@[T\?.GY2@D.)P#IW)]=4,1] 9'/:&O7[O:# XS!1[GCP]PLFW M$_ECBAAT1+4).UDQ/.HN.+\_\?V'AX?>P[!'Z-P?'!ST_7\^7]X$"XB1AQ/& M41) MR/T)RP]>$D"Q-.<,Z>OIC32 8;^4UU.A?S+TS)/'O+Z V_8[ZU8V%4I MRN(:E6CYJJ!7GOK'Q\=^6OHD%8%P2>B,[53/^T_BK/ H_2OD7='(G+9$9HG+:N MJ#J-QQ_O8=1E.+Z/0!];4)B-NM\9%@TW.#PX.CB6S?9K>3@_DR2B@PKC8^BJ#HM1Z/JMI*LC])TTV@[R$I\AD0.(B^$&5I&?(^I(7:8KS5Z-FO1 M27""Y7B[%'_F*H85AR2$4%R\O,(S0TXUC)ES2AK+YXR$S7Y&"$4H$$S@'3G MF #%1$Q"X4>Q_G2,(JO&&$Z&IKW@ZIC:<( 9H13(8;,@SS$+4/0O('HNCIB3 M>87*@%E0M1]GN;$-@1:"*:2';X%TW;NJH5IT5JPYW;Z =9O;"FTNG()[U S< M=8[GXK;^RS+;,+E55[$XM]S*%K>78(65FN"*412OWYKD=0USD1P5*_DO*#:O MDV62'#=3TG9VI98VXF=&4@Q_;Y+AJ1C^%$47XDYM]1<\6B$Z-#F*!4W;,9:; MVHAC(90"^4>3("^2@-![0M/;Y1LN%EVG9"GR>CPEH7ULUCHC![GBC+8CW\3P M1AV@(K#J#L=-=H=;M+H(1;_$,[S>O"ZYL%9H1KFGNA72'SW0;VH?*97(J/E[16_*0E+$M MJFQDLZH]X>HTM@W5;##-M*&-J%P>Z6+OBDXH^8'77Y\[P3JD-KH%Z9X@+K>X M#>="1 V[T8TIW>G6B_K2T9N76(>NENP)5+NEK0:MCJ0A-KI;I9*8$,91]!^^ M=]X7EPEM0 WAGF ML[<-7".>1MS09I:\'HPI( M46Y'RF2]J+[@2"S51Y2-H M. UM4,GGYZ+)@B3VW7U7L7)8+&XOJ HK-6$5HVA@#6TAW4"PI"*[_F!Z*S,W M@+F*E_Y0F@$H4R:E6TEUFUH9KDK($TOX;V:?00/UL%"Y3,P?*- M9YG$F!KSDO8BK&%IPRDR'TE#;'0[YBP&.A<)?J+D@2].27R/$OM-7:DR=RO@ M4+:7;'V#&]T,. )JS@UMT7P5/8U#(JJ/EXGZ;L9\3JA4HZP[-.VE6L=439Z. M4)ID0_LO-R3" 9;9?48<*$;FZL8MT%.N1=!>@)5VZDZWEC@:74.[+A,*LO- M$D#ZP+5\&8!>S6:%^[]JH?)>)FPOTMKV:J(MBZ<1-[3K8J1RP=@2:&W03KD= MMT6^-]"KK&Z'WA)5=X!&'SW2N=ZB:6&OH$216T 9BMX?V3("(,PE&7TR6L#Y"$PXJ?12GW49?!7'YX.>(98M.TD9;,FR-T MO^8,$6?ZR#-P=> N_4Y&5G\:(<:N9C>9+<(7G7B=KQKNH9: M38W4\)1EZHR8[KM;(NTATCOS.9LWA)I_Y?E%5 NV7L#U;K#;M]6V(BL6!_(! M5)'49[!\T^(LUU2+Y6^TQ"H9@:3:1Q9C,5+*KQCAA<.R\,\)Q(&[:P@!8CG- M?T54/NC/SE"P^+H@3P?.5N(BA)F4G!-ZE<#- E&XFJ5ICS-IRA/'?)RH$V!" M<2!T_?[1P01H>I:5^5NFH'"\30JM[+DMH%$].-XFR>+D^]0WO\/4$L#!!0 ( ):!J5@0)ZOWA0H /)J 4 <7-I+3(P M,C0P-3 Y7VQA8BYX;6S-G5%OX[@1Q]\+]#OPW#[T@'4#IW08I&$4#7Z9_?E/GW\:#G_%":9!AA=H M_H+^04FPH-%BA='MW%X]*^O5_?A(UX'PRA)LR )\0 Q M_7&:-UZ1,,CR,5>Z;^-WR'(EC/^@;S&-R.(\6;0_ M<#544X._SP+Z#JCHP?PGT/ZH@:'&O.F*_2;%Q=L,)PN\$)&Y;\NU,P^=7VQS MSSO?))2\QGP7(52?3LJ\YAZ703K/W;*]_GT7X:^M1/J5S&@(9B M?.S7FCF5BE%(V-ZZR8;2]):4K&T%(@XY+5.4^SU&F@QE!%E\C+H -@[2]&:9 MC^,+60=1HA)K% AD 8$OL\:8WM!"GJW4ZAUF>1LB2P%NT=XUN.8Z$9?,*NAJ M.HG=^I*_"[QLR\OP&B=9=4"GVRA5N*K5E9.WZ#R)KAV!+]BV #:^S?TTS'EK MQY#7%Y*\(N9K1 M(,RT&PO MKNID&QO1-DX@K>B"SF$4-5UL_PE([)LZ/K2"^:>6%*FWB=4))PV MH%_[='TAX1,G^X%Y5$H/F(7XRVZA G-.S+F2 MD:HJ!%'64K4 U#<:9>R=&[_1?4JBXIF=NC-;->64#!H/UJQ1?: S.3;1!^MG M93.2V[OET5XIXI!8F5!0*E!U*WD+S-Z3. JC+$I67]E&3Z,@5O Q"\0])"#P M0-4=7 M;_XLC-XLE]JSI7IA.5&;T /5^O@^R%J]F]"U=)HQVS"L&%%A1;FY6Y@=*DE< M'74X0&O$:V78:74T]3">CEED1<\^D4+Y@JAMQ2C+\U$$1JP\@ZB!H MG>7B#^;U- ,ZD&=)UQC10/3FF):=NU%=[:-Q71C[1S940Y!M<[%!NBMRF&\; M%"T2OOLLRQ?V'M5 -ZA1R%8T#5 -1FV":-5Q'P(A#O!<4:K<2E4>L-:D@KHZ:']_IP M&I'_*JD+8U\K]MYBQ4BJ#\6' !&AJ-0B+N[#XG&#@+RZ2M!"LG:4E]/K2&MM M49VO,5U%R>I72IZSQS.RW@0)?'-N54J+R*#T7CS6$?@O&I-[^V*!>XE%(JRH M,*/2WH=U8:\G<4X\M [ #C+_;I"TQOWI8L%X2\L?5U&"QR#U%IW$/*CS)MX2 MW9]WV+F==JB/8+UL_"!^0=R,;I)>[ *V.A+'E$.D W*9.E$\=*9^V0OFT M3C;<[/V*\W]($\JU\XK5%!C%=5 M31&N1VZ,;\FU$]V5'AK;W,;?L7)KCZ@&*@#/)LP:!MFO.WOC?T MEI(?4:+!Y2*%N-:D3<%M&$-CA.O^G3!7NVFL[Q[/"$F/@#?5%:+>S@"$OM(# MY+\.E]8OZ<6C'^OU7): %W,A:>Q*+L=L[C*^\^MV#2_E^@6\,/0(9;5*X(4; MK"1XU2X?I8*7;$.QVT;UEJ19$/\GVAB?NMN$$+:*L"EXP?B-(:QZ=P)9[J3A M7)@1L_?FX;FUEA#>D ""&UT$! MLC_C.0%5V2R_->8O>T BF'1B3I9,6U6Q.R' 5JL6B.+G+L:WCR2!/TMB,I<3 MT=)EB^1 &^#11IDEG>0O*FWKQ%W=C,8@]@3)UJDJ05UO+UK;OJRCEW[]- M'X)Y#._;H$+:L!6%]TX-1O3?HE6W]KU95HM-6;2BW_/VCL])L16(U&84VGXE MH;SOVJO<.J#\H=IEAM?J%TQJ5""H%55CL&J1FP.VZMH-VGT/'5QN0[FQ5_3J ME0,)-A48I'@GADDV8]#&01@X?*(L^'@R?^!#5H RFDP<:\-/( M[U_6_"].&N1 M2'U2X=VYJE1W:&NM74C]7YJS^/'PT^%1SB-K^'Z'%QBO^5NI;P'E7[M+SX/P M\=LCV36<;S$-HY1++@B]2?#]8T#QS3(_*/6T8YKW H].['$)9AFZ&\,;UVE79OL?SV/OSG5T/'KKR=#NFV3XT>BYC?T"8 M.4'//+QH1'@_ +0D%/%'DBGWQM^Q%&&ULU5Q=<^(V%'WO3/^#2Y_Y3K8EL]D=RB8=IMG !#K;]F5' MV (T:TNL9#;DWU;]QTT4>C\@98C@ZUJ[ MT:IY$/LD0'AQ75NS.F ^0K6/'W[^Z?TO]?J?$$,*8AAXLR?O#TI 0%&P@-[X M831'(?0Z%XUNH]VX['0N4LWUNC@]1/C;E?@Q PQZO%O,KC8,7=>6<;RZ:C8? M'Q\;C]T&H8MFI]5J-__Y?#?QES "=819#+ /:Q['7['DX!WQ09S$G#I],Z.A M(N@V=WT5(L1?=06KBT/U=J?>;3':O*1!-#.,[,(,A[S(Y/7Y:P>L:0]$J MA.K8DL*YF2>D=$4QX"V&F*8E!>)HX$[Y\K+ENC@_Z M_E2IM85\?\HL\T$.7R'+J6Z.#WH,*2+!#0Y>/G"]JU,%/XD!?06KY#L[7L#+ M1[U'J-_7 ,?KJ,Y0PR?1EOP3\=<1Q'$?\\+%*'X:XCFA4;(RE,?]G2$>5N>B M==GJ)4'9Z=)!KBAD')BTW/$#F;[@)H8X@('J381ZN(RD5]5O2/Q,5Z%8!@G- MUX/QKI)B,.@W%N1',X"(%[C3%1^$ZFZBF/_Q=4#X^M^?L9@"/U9,H2C,=0EXZBD\D @CK MSBH$*'L9 &^BA$01P4D8GV$T@S0W1 K:=\,DUYZ5D9Y+^C0K"5!?T?&/F8DD M?\$H$XM.,4< M4BHG?HN61$B87AWVJGIN:N<'OC[ /);!S[DOP!*^33,;H"__+(DNP,W&TA] MQ 3DEM 1AI,ES^5HGFCMI[2)$_M\OI8GP#%%/L>UVYE0956\3IARX[1,-W%OFB22JL0-G*%'(FTYZ!Z\3SWBNFSW89 M1:I?DF3S9R 5F;.0O<7"<=0E*;\3@$.N1K^&*T$9+TU3J)>7H6Y IIQ1B]W4 M) /.-CGBUGQVB56$S:0[+F'4+,<9>+//HPU$Q+1=;>0UHCDP[HG($#;A'S0?@O M!/26']'7G1*4YH(VMQ-R=-(+W;/QPM;+Y6XPX(Q^R.#.QQ'%\@[T M1(90NN+"85=LA=VB$-ZO#1L11)Y'EGH2^<+_0 72.S$ MX_@>1.9M<3,D4W =XG[1K:+V++S.)8O_SOGB#[A("L(A#N#F+_ADK'X!)E/^ M',;]^MME[6F ')ETP&_..V"(?4)7A"9*DRV5 5ES,4\#$IAG@TIG9-Q11]-P688<-UHCK;/5UDN'DJP&>\48MUW3369>_JED%0Z MI>>\4_I!P"4S^4M(;!M=8L%E'&+$N>^.T;;H/MO"Y0W,3/@#_G%$ MI^11?TBH!&6R1!IU-H8HE':8'=)TR@PN[V!F@D^NGD=T3,D/M'WHO] 1!5"3 M+7+0L_&&7>1A!LEQ*I>XOZ.I++Z]O;+.%UF(<;)0D+-Q@UG4@=.$XE+5=W^; M4T8^)BP&X7]H5;B]80.:G* !S\8/-H&'N4)C5-YP>1=4K'=]"H'!#:8FF9YL MD\L5MXBH7.,LAZJJRSN;XA6_<+PDV/P?K*)FF9A\L\L5+A%3N M)]!?4RZIW9E-A6"MTD7-,CGY9IB+)Y?V_>Y()VO#0H04A\V-$N%SL8=/S40W&W\)\ (:'D"P0;19/ MQN?851.T]FV>Y5/7=W\B[B2!=<%5_4O(8 M+P*>]V8%E,H@+F_N?>&^CB$6KR"ML?QOI_YH MHA4C,U: <=D.5615-D(!F;* RSMW$Q(B'PE)GT$,*0+ZI5\Q0*T.!H#+E2\5 M5'UE,#"IFKN\7S>F4%@58C]YNVLJOA&!CN;SW'U\.5"FS 9TV0N5!5;VA(U1 M>ZAG#+S*.:?:$W3GA=6RM._QNFHA MU?F^+&W^CI=>#6^B6^:V[:('^*;V3[\ M#U!+ 0(4 Q0 ( ):!J5AP"H/I,Q0 +Z2 1 " 0 M !E9C(P,#(X-S W7SAK+FAT;5!+ 0(4 Q0 ( ):!J5BJ9NI$?RT -Q. M P 5 " 6(4 !E9C(P,#(X-S W7V5X.3DM,2YH=&U02P$" M% ,4 " "6@:E8.]K%?K(& "6% %0 @ $40@ 968R M,# R.##DY+3(N:'1M4$L! A0#% @ EH&I6.QG/W'R P EQ$ M ! ( !^4@ '%S:2TR,#(T,#4P.2YX1X' !91@ % @ $930 <7-I+3(P,C0P M-3 Y7V1E9BYX;6Q02P$"% ,4 " "6@:E8$">K]X4* #R:@ % M @ %I5 <7-I+3(P,C0P-3 Y7VQA8BYX;6Q02P$"% ,4 " "6 M@:E8Q$6GT"H' #D3@ % @ $@7P <7-I+3(P,C0P-3 Y >7W!R92YX;6Q02P4& < !P#) 0 ?&8 end XML 20 ef20028707_8k_htm.xml IDEA: XBRL DOCUMENT 0001816431 2024-05-09 2024-05-09 0001816431 us-gaap:CommonStockMember 2024-05-09 2024-05-09 0001816431 qsi:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassACommonStockEachAtAnExercisePriceOf1150PerShareMember 2024-05-09 2024-05-09 false 0001816431 8-K 2024-05-09 QUANTUM-SI INCORPORATED DE 001-39486 85-1388175 29 Business Park Drive Branford CT 06405 866 688-7374 false false false false Class A common stock, par value $0.0001 per share QSI NASDAQ Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share QSIAW NASDAQ false